Home

EIRY ROBERTS

CIK 1727606 · Chief Medical Officer · last filed 2026-05-26

EIRY ROBERTS is a Chief Medical Officer who has filed 54 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for BHC, was dated May 26, 2026. Across all open-market trades the lifetime net is −$21.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.88M

Companies

3

Total Filings

54

Lifetime Open-Market Net

-$21.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BHC Director 45,871 $6.25 $286.7K $0 1 2026-05-26
AMICUS THERAPEUTICS, INC. (FOLD) Delisted Director 0 $14.49 $0 $0 6 2026-04-27
NBIX Chief Medical Officer 34,252 $163.41 $5.60M -$21.23M 35 2025-02-14

Recent Filings

54 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-26 BHC Grant (A) +45,871 $0 EDGAR
2026-04-27 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Disp (D) −76,275 -$1.11M EDGAR
2025-06-06 AMICUS THERAPEUTICS, INC. (FOLD) Delisted Grant (A) +20,414 $0 EDGAR
2025-02-14 NBIX Notice (144) −500 -$57.5K EDGAR
2025-02-14 NBIX Mixed +2,387 -$258.3K EDGAR
2025-02-13 NBIX Notice (144) −604 -$70.8K EDGAR
2025-02-13 NBIX Notice (144) −1,114 -$130.5K EDGAR
2025-02-12 NBIX Mixed +880 -$115.9K EDGAR
2025-02-10 NBIX Notice (144) −980 -$120.2K EDGAR
2025-02-04 NBIX Mixed +1,312 -$222.6K EDGAR
Showing 1–10 of 54
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.